Innovate UK’s sustainable medicines manufacturing grant closes Dec. 2: What UK small firms must cover
A small firm can join a consortium seeking £1 million and still have to finance most of its own work. In Round 2 of Sustainable Medicines Manufacturing Innovation, Innovate UK caps support for commercial experimental development at 45% of eligible costs for micro and small organisations. Applications close at 11 a.m. UK time on December 2, 2026.

What each partner has to finance
Innovate UK and the Department of Health and Social Care have set aside up to £7 million for the competition, subject to receiving enough high-quality applications. Funding is competitive. The standard £500,000 to £1 million range applies to the consortium’s grant request, not to each partner’s request or the total project cost.
For example, a small partner with £200,000 in eligible commercial experimental-development costs could seek up to £90,000 and would have to cover at least £110,000. The cap rises to 70% for a micro or small organisation doing commercial industrial research. Medium and large organisations have lower caps, and separate rules apply to research organisations doing non-economic work.
The application asks how each partner will finance its contribution. Companies must also identify the funds available for the project and explain how they plan to finance further development after it ends.
